跳至主要内容
临床试验/JPRN-UMIN000035844
JPRN-UMIN000035844招募中未知

Examination of efficacy and safety treated by denosumab or zoledronate in glucocorticoid-induced osteoporosis - Efficacy and safety treated by denosumab orzoledronate in GIO

Dept. of Orthopaedic Surgery Shinshu University School of Medicine0 个研究点目标入组 60 人开始时间: 2019年2月13日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 110years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1 Patients who have taken denosumab or zoledronate before 2 Patients who are allergic to denosumab or zoledronate 3 Pregnant or breast-feeding patients 4 Renal failure (Ccr is less than 35 mL/min) 5 Dehydrated state 6 Hypocalcemia

研究者

发起方
Dept. of Orthopaedic Surgery Shinshu University School of Medicine

相似试验

Examination of efficacy and safety treated by... | 临床试验